{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:22:50Z","timestamp":1776414170208,"version":"3.51.2"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","funder":[{"name":"NIH","award":["U19 AI 166059"],"award-info":[{"award-number":["U19 AI 166059"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Incidence of pediatric coccidioidomycosis has risen over the last 20 years, and coccidioidal meningitis is the most severe form of disseminated disease. Intrathecal amphotericin B deoxycholate (IT AmBd) has historically improved outcomes and remains a mainstay of therapy when response to azole therapy is inadequate. However, the dosing, route of administration and duration of therapy in young pediatric patients pose unique challenges due to their anatomy, inability to communicate and the need for hospital-based administration. We present 4 instructive cases over 30 years to provide guidance on the use of IT AmBd.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Case information was abstracted from the electronic health record at University of California Los Angeles. Literature review was conducted to look for additional cases on Pubmed with relevant search terms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We present 4 cases including 2 patients with successful outcomes and 2 who did not survive. Starting doses, administration routes, complications and neurosurgical challenges are described. Patients had prolonged hospitalizations as the ability to administer outpatient IT amphotericin B was minimal. Therefore, more rapid dose escalation and weaning, with a shorter overall duration of therapy, was needed than described for adults. IT treatment was considered an initial stabilizing measure while attempting to optimize azole monotherapy. Cisternal administration is preferred but remains a logistical challenge.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Intrathecal AmBd remains an important treatment option in pediatric patients with refractory coccidioidal meningitis; however, due to unique administration, challenges may be more of a temporizing measure rather than definitive prolonged therapy. Further experience and multidisciplinary care are needed to reduce mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004888","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:03:54Z","timestamp":1760375034000},"page":"e414-e418","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Pearls and Pitfalls of Intrathecal Amphotericin B Therapy for Refractory Coccidioidal Meningitis in Children: An Illustrative Pediatric Case Series"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2485-3927","authenticated-orcid":false,"given":"Sanchi","family":"Malhotra","sequence":"first","affiliation":[{"name":"Departments of Pediatrics, Division of Infectious Diseases at David Geffen School of Medicine at UCLA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Adachi","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics, Division of Infectious Diseases at David Geffen School of Medicine at UCLA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aria","family":"Fallah","sequence":"additional","affiliation":[{"name":"Neurosurgery at David Geffen School of Medicine at UCLA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Royce","family":"Johnson","sequence":"additional","affiliation":[{"name":"Medicine at David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishminder","family":"Kaur","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics, Division of Infectious Diseases at David Geffen School of Medicine at UCLA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"McCarty","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases, Keck School of Medicine, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Krogstad","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics, Division of Infectious Diseases at David Geffen School of Medicine at UCLA"},{"name":"Molecular and Medical Pharmacology at David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"R1-20251013","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/jof8070666","article-title":"Update on the epidemiology, diagnosis, and treatment of coccidioidomycosis.","volume":"8","author":"Williams","year":"2022","journal-title":"J Fungi"},{"key":"R2-20251013"},{"key":"R3-20251013","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis.","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R4-20251013","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw794","article-title":"Intrathecal amphotericin B: a 60-year experience in treating coccidioidal meningitis.","volume":"64","author":"Ho","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R5-20251013","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/clind\/16.2.247","article-title":"The natural history of coccidioidal meningitis: Va\u2014armed forces cooperative studies, 1955\u20131958.","volume":"16","author":"Vincent","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R6-20251013","first-page":"339","article-title":"Coccidioidal meningitis. The use of amphotericin B in treatment.","volume":"94","author":"Einstein","year":"1961","journal-title":"Calif Med"},{"key":"R7-20251013","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/INF.0000000000002470","article-title":"Extrapulmonary coccidioidomycosis among children in central California: a retrospective review.","volume":"38","author":"Naeem","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20251013","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/INF.0000000000003813","article-title":"Central nervous system coccidioidomycosis in children: a retrospective case series.","volume":"42","author":"Naeem","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20251013","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jpids\/piu091","article-title":"Coccidioidomycosis: experience from a children\u2019s hospital in an area of endemicity.","volume":"5","author":"Dimitrova","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R10-20251013","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/INF.0000000000003017","article-title":"Isavuconazole as salvage therapy for refractory pediatric coccidioidal meningitis.","volume":"40","author":"Naeem","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20251013","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa2000024","article-title":"Disseminated coccidioidomycosis treated with interferon-\u03b3 and dupilumab.","volume":"382","author":"Tsai","year":"2020","journal-title":"N Engl J Med"},{"key":"R12-20251013","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.clinthera.2019.08.011","article-title":"Host\u2013pathogen interactions in coccidioidomycosis: prognostic clues and opportunities for novel therapies.","volume":"41","author":"Krogstad","year":"2019","journal-title":"Clin Ther"},{"key":"R13-20251013","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/jof6030122","article-title":"Review of the novel investigational antifungal olorofim.","volume":"6","author":"Wiederhold","year":"2020","journal-title":"J Fungi"},{"key":"R14-20251013","doi-asserted-by":"crossref","first-page":"e00999","DOI":"10.1128\/AAC.00999-18","article-title":"The orotomide olorofim is efficacious in an experimental model of central nervous system coccidioidomycosis.","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-20251013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/jof5030054","article-title":"Central nervous system infections due to coccidioidomycosis.","volume":"5","author":"Jackson","year":"2019","journal-title":"J Fungi"},{"key":"R16-20251013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-119-1-199307010-00005","article-title":"Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group.","volume":"119","author":"Galgiani","year":"1993","journal-title":"Ann Intern Med"},{"key":"R17-20251013","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-124-3-199602010-00004","article-title":"Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?","volume":"124","author":"Dewsnup","year":"1996","journal-title":"Ann Intern Med"},{"key":"R18-20251013","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00006454-199206000-00001","article-title":"The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis.","volume":"11","author":"Bonadio","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"R19-20251013","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/mmy\/myv047","article-title":"In vitro interactions between amphotericin B and hydrocortisone: potential implications for intrathecal therapy.","volume":"53","author":"Hodge","year":"2015","journal-title":"Med Mycol"},{"key":"R20-20251013","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/cix318","article-title":"Adjunctive corticosteroid therapy in the treatment of coccidioidal meningitis.","volume":"65","author":"Thompson","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R21-20251013","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cid\/ciac478","article-title":"Controversies in the management of central nervous system coccidioidomycosis.","volume":"75","author":"Thompson","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R22-20251013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/497596","article-title":"Coccidioidal meningitis.","volume":"42","author":"Johnson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R23-20251013","doi-asserted-by":"crossref","first-page":"e01715","DOI":"10.1128\/AAC.01715-18","article-title":"APX001 and other Gwt1 inhibitor prodrugs are effective in experimental coccidioides immitis pneumonia.","volume":"63","author":"Viriyakosol","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:09:36Z","timestamp":1760375376000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004888","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}